Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0PU6F
|
||||
Former ID |
DNC005880
|
||||
Drug Name |
2-(1H-benzo[d]imidazol-2-yl)quinoxaline
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529313] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H10N4
|
||||
Canonical SMILES |
C1=CC=C2C(=C1)NC(=N2)C3=NC4=CC=CC=C4N=C3
|
||||
InChI |
1S/C15H10N4/c1-2-6-11-10(5-1)16-9-14(17-11)15-18-12-7-3-4-8-13(12)19-15/h1-9H,(H,18,19)
|
||||
InChIKey |
AYFBMQMYJRNGIM-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A2a receptor | Target Info | Inhibitor | [529313] | |
Adenosine A1 receptor | Target Info | Inhibitor | [529313] | ||
Adenosine A3 receptor | Target Info | Inhibitor | [529313] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
RANKL Signaling Pathway | |||||
Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.